| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |
| 05/23/2000 | CA2165162C Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 05/18/2000 | WO2000028040A2 Cloning of rhadinovirus genome and methods for its use |
| 05/18/2000 | WO2000028020A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | WO2000028016A1 T cells specific for target antigens and methods and vaccines based thereon |
| 05/18/2000 | WO2000028011A2 Fk506-based regulation of biological events |
| 05/18/2000 | WO2000027186A1 Adult t cell leukemia model animal |
| 05/18/2000 | CA2350086A1 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | CA2346962A1 Fk506-based regulation of biological events |
| 05/17/2000 | EP1001032A2 Recombinant retroviruses delivering vector constructs to target cells |
| 05/17/2000 | EP1001024A2 Protein encoded by the trkB proto-oncogene, used in assay systems for neurothophin activity |
| 05/17/2000 | EP1001019A1 Transgenic animals harboring APP Allele having Swedish mutation |
| 05/17/2000 | EP1000166A2 Inhibitors of cell-cycle progression and uses related thereto |
| 05/17/2000 | EP1000161A1 Anticoagulant fusion protein anchored to cell membrane |
| 05/17/2000 | CN2377834Y Silkworm eggs incubation newly-hatched silkworms collecting bag |
| 05/17/2000 | CN1253567A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/16/2000 | US6063983 Monoclonal lymphocytes and methods of use |
| 05/16/2000 | US6062945 Process for rearing bumblebee queens and process for rearing bumblebees |
| 05/16/2000 | US6062224 Movement-response system for conducting tests on freely-moving animals |
| 05/11/2000 | WO2000026357A2 Transgenic and cloned mammals |
| 05/11/2000 | WO2000026343A2 Tissue specific promoters and transgenic animals for the screening of pharmaceuticals |
| 05/11/2000 | WO2000025578A2 Methods for cloning animals |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | CA2525148A1 Transgenic and cloned mammals |
| 05/11/2000 | CA2350233A1 Transgenic and cloned mammals |
| 05/10/2000 | EP0999278A1 Vascular specific regulatory elements contained in the desmin 5' flanking region |
| 05/10/2000 | EP0999269A1 CDNA sequence and genomic organization for a 59.4 kDa neuronal-specific 7 transmembrane protein (pNEU60) |
| 05/10/2000 | EP0999194A2 Waste treatment system |
| 05/10/2000 | EP0998574A1 Methods of performing homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acids |
| 05/10/2000 | CN2376736Y Drawer type combined cabinet for three-D effective breeding of Huangfen worm |
| 05/09/2000 | US6060643 Mouse model with human immune system |
| 05/09/2000 | US6060081 Transporter is one or more di-c10-20 alkylamide glycylspermines. |
| 05/09/2000 | US6060049 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 05/09/2000 | US6058878 Protozoan free colonies of lepidoptera |
| 05/04/2000 | WO2000024917A1 Targeted gene modification by parvoviral vectors |
| 05/04/2000 | WO2000024912A1 Use of a self-cleaving rna motif to modulate gene expression |
| 05/04/2000 | WO2000024888A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60) |
| 05/04/2000 | WO2000024880A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 05/04/2000 | WO2000024875A1 Compositions and methods useful for treatment of depressive disorder based on an animal model |
| 05/04/2000 | WO2000024759A1 Systemic delivery of gene products via skin |
| 05/04/2000 | WO2000024415A2 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 05/04/2000 | WO2000024254A1 Compositions and methods for modulating expression within smooth muscle cells |
| 05/04/2000 | WO2000024246A2 Transgenic fish carrying plasmid for mutation detection and methods |
| 05/04/2000 | WO2000002897B1 Delta cleavage products and methods based thereon |
| 05/04/2000 | WO1999060146A9 Adeno-associated virus vectors and uses thereof |
| 05/04/2000 | WO1999053021A9 Cell differentiation/proliferation and maintenance factor and uses thereof |
| 05/04/2000 | CA2348835A1 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 05/04/2000 | CA2348778A1 Targeted gene modification by parvoviral vectors |
| 05/04/2000 | CA2347075A1 Cdna sequence and genomic organization for a 59.4 kda neuronal-specific 7 transmembrane protein (pneu60) |
| 05/03/2000 | EP0996727A1 Gene conferring obese phenotype |
| 05/03/2000 | EP0996715A1 Heterologous expression of proteins by "rescued" vector comprising an intron |
| 05/03/2000 | EP0996708A1 Transgenic nematode model of triplet repeat neurological diseases |
| 05/03/2000 | EP0996707A1 Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof |
| 05/03/2000 | EP0669977B1 Transformed endothelial cells |
| 05/03/2000 | EP0624100B1 Dna encoding a human serotonin receptor (5-ht 4b) and uses thereof |
| 05/03/2000 | EP0460042B1 Vector for integration site independent gene expression in mammalian host cells |
| 05/02/2000 | US6057298 Administering to treat skin cancer |
| 05/02/2000 | US6057145 Heat sterilizing artificial liquid medium of starch, dextrose or sucrose, and phosphate buffer impregnated in sponge, inoculating with host fungus, inoculating with nematodes whose surface has been sterilized, and incubating |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023600A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023400A1 Worm composter |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000022921A1 Method for localizing allantoic fluid of avian eggs |
| 04/27/2000 | WO2000000618A3 Polyketides and their synthesis |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999050406A9 Growth differentiation factor-9 regulatory sequences and uses therefor |
| 04/27/2000 | DE19849073A1 Transgene encoding amyloid precursor protein or its fragment, used to produce transgenic nematodes used, e.g. to screen for agents for treating Alzheimer's disease |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/27/2000 | CA2343974A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | CA2339862A1 Method for localizing allantoic fluid of avian eggs |
| 04/26/2000 | EP0994945A2 Smad-interacting polypeptides and their use |
| 04/26/2000 | CN2375101Y Maggot culturing device |
| 04/25/2000 | US6054633 Live mouse mutagenesis systems for testing mutagenic agents in vivo |
| 04/25/2000 | US6054558 Amino acid sequence of isolated polypeptide from gene upregulated in endothelial cells in response to shear stress; for treatment and diagnosis of atherosclerosis, hypertension, ischemia/reperfusion, restenosis, and arterial inflammation |
| 04/25/2000 | US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy |
| 04/25/2000 | US6054147 Feeding poultry a higher amount of omega-3 highly unsaturated fatty acid (hufa) in the late phase of poultry's production than in earlier phase; side effect reduction |
| 04/25/2000 | US6054116 Chimeric mouse for human and mouse immune systems |
| 04/25/2000 | CA2150802C High density rearing system for larvae |
| 04/20/2000 | WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 04/20/2000 | WO2000022111A1 Method for generating diversity |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021362A1 VIABLE PrP (PRION PROTEIN) TRANSGENIC ANIMALS AND METHODS OF USE |
| 04/20/2000 | WO1999067407A3 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/20/2000 | WO1999057266A3 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 04/20/2000 | WO1999053062A3 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 04/20/2000 | CA2675802A1 Use of an immunoglobulin-producing cell line to gererate diversity in a gene or gene product |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | CA2092195C Retroviral packaging cell line |
| 04/18/2000 | CA2076068C Method and apparatus for inducing controlled stressed behavior in animals, such as enhanced eating, drinking, mating, maternal or the like behavior |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020592A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 04/13/2000 | WO1999035241A9 Transgenic rabbit that expresses a functional human lipoprotein (a) |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |